Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 4

2(22.2%)

Phase 3

1(11.1%)

9Total

N/A(6)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03983512Not ApplicableActive Not Recruiting

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Role: lead

NCT03110861Not ApplicableCompleted

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

Role: lead

NCT01512563Not ApplicableCompleted

Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent

Role: lead

NCT02730663Not ApplicableCompleted

A Study to Evaluate the Effectiveness and Safety of EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent'

Role: lead

NCT03857958Not ApplicableUnknown

Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction

Role: collaborator

NCT01597570Phase 3Terminated

Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System

Role: lead

NCT02460432Not ApplicableCompleted

Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

Role: lead

NCT01041612Phase 4Completed

Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

Role: lead

NCT01788865Phase 4Unknown

Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction

Role: collaborator

All 9 trials loaded